Davion Appoints New Chairman, Chief Operating Officer, and Non-Executive Director

Davion Healthcare Plc, a leading medical device manufacturer, has today announced the appointment of Sir Eric Peacock as Chairman, Mr Jon Chadwick as Chief Operating Officer and Mr Julian F. Sluyters as Non-Executive Director.

Sir Eric Peacock has a wealth of experience in international business and has held several government roles. He was knighted in 2003 for his services to International Trade and is currently Chairman of a number of companies, including IPro Sport Holdings Ltd, Buckley Jewellery Ltd, Stevenage Packaging Ltd, Kingfisher Beer Europe Ltd, and is also a Senior Non-Executive Director of Bango Plc. Additionally, Sir Eric is Chairman of two charities, The Big Cat Sanctuary and Uniqueness, which focus on disadvantaged children and young adults.

Mr Jon Chadwick brings nearly three decades of experience in the financial services industry, particularly in the fields of Med Tech and Bio Tech since 2019. He has established himself as an expert in fostering collaborative partnerships and leveraging his extensive network, to help businesses grow and succeed in the Med Tech and Bio Tech industries.

Mr Julian F. Sluyters has held various leadership roles in asset management firms and has served on over 20 different mutual fund boards in the US and Europe. He has expertise in private equity and alternative asset classes and currently advises EQX Biome, a biodiversity impact company.

Jack Kaye, CEO of Davion Healthcare Plc, said: “I am delighted to welcome Sir Eric Peacock, Mr Jon Chadwick and Mr Julian Sluyters to the Davion Board. I know they will all make valuable contributions to the ongoing success of the company.”

Davion Healthcare Plc is committed to delivering exceptional value to its shareholders and driving innovation within the medical sector. The company is preparing for the listing of its ADR’s on the NASDAQ stock exchange early next year.

Today, Davion Healthcare Plc has announced the appointment of Sir Eric Peacock as Chairman of the company, along with Mr Jon Chadwick as Chief Operating Officer and Mr Julian F. Sluyters as Non-Executive Director. With a wealth of experience in international business, financial services and government roles, these three board appointments come as the company prepares for the listing of its ADR’s on the NASDAQ stock exchange early next year.

Jack Kaye, CEO of Davion Healthcare Plc, said: “I am delighted to welcome Sir Eric Peacock, Mr Jon Chadwick and Mr Julian Sluyters to the Davion Board. I know they will all make valuable contributions to the ongoing success of the company.”

Sir Eric Peacock brings a wide ranging experience of start-ups, turnarounds, financing, acquiring, disposal and floatation with a notable international background. He is Chairman of IPro Sport Holdings Ltd, Buckley Jewellery Ltd, Stevenage Packaging Ltd, Kingfisher Beer Europe Ltd and is the Senior Non-Executive Director of Bango Plc. Additionally, he is Chairman of two charities, The Big Cat Sanctuary and Uniqueness.

Mr Jon Chadwick has established himself as a seasoned professional with a knack for identifying opportunities and driving impactful strategies in Med Tech and Bio Tech. He has leveraged his extensive network to help businesses grow and succeed in the industries.

Mr Julian F. Sluyters has had a 40-year career in the financial services industry and has extensive board experience, having served on over 20 different mutual fund boards in the US and Europe. He has expertise in private equity and alternative asset classes and currently advises EQX Biome, a biodiversity impact company.

Davion Healthcare Plc is committed to delivering exceptional value to its shareholders and driving innovation within the medical sector. With the appointment of their new board members, the company is well positioned to achieve its goal of listing its ADR’s on the NASDAQ stock exchange early next year.

Davion Healthcare Plc is a leading medical device manufacturer whose mission is to create and manage an environment for the secure development of new medical devices. The company is focused on providing accessible products available for self-use in the comfort of the home utilising smart technology interfaces, to empower individuals to take control of their health and wellbeing.

Derick is an experienced reporter having held multiple senior roles for large publishers across Europe. Specialist subjects include small business and financial emerging markets.

Leave a Reply

Your email address will not be published. Required fields are marked *